6856:TSEHoriba , Ltd. Analysis
Data as of 2026-06-11 - not real-time
¥24,800.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
HORIBA’s share price is comfortably above both the short‑term and mid‑term moving averages, reinforcing the bullish trend indicated by the overall trend direction. However, the MACD line sits below its signal line and the histogram is negative, suggesting a bearish momentum divergence, while the RSI hovers around the midpoint, indicating neutral short‑term pressure. Volume has been tapering off and volatility remains elevated, which adds a layer of short‑term uncertainty.
Fundamentally, the company delivers robust top‑line growth in the high‑teens percent range, solid margins, and a cash‑rich balance sheet with modest debt. Its price‑to‑earnings multiple is notably lower than the industry average, and the dividend yield just above one percent is backed by a payout ratio well under one‑third, supporting sustainability. Analyst consensus leans strongly toward a buy, and the current price sits between the mean and median target levels, indicating limited upside but a fair valuation relative to peers.
Fundamentally, the company delivers robust top‑line growth in the high‑teens percent range, solid margins, and a cash‑rich balance sheet with modest debt. Its price‑to‑earnings multiple is notably lower than the industry average, and the dividend yield just above one percent is backed by a payout ratio well under one‑third, supporting sustainability. Analyst consensus leans strongly toward a buy, and the current price sits between the mean and median target levels, indicating limited upside but a fair valuation relative to peers.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above short‑ and mid‑term moving averages
- bearish MACD divergence
- decreasing volume and high volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth and solid operating margins
- valuation discount to industry PE peers
- healthy cash position and sustainable dividend
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- consistent earnings expansion across diversified segments
- low debt‑to‑equity and resilient balance sheet
- positive analyst sentiment and strategic exposure to environmental and healthcare markets
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin10.88%
P/E Ratio28.2
ROE11.58%
ROA6.84%
Debt/Equity18.27
P/B Ratio3.0
Industry P/E36.1
Technical Analysis
TrendBullish
RSI50.8
Support¥23,650.00
Resistance¥28,200.00
MA 20¥25,624.00
MA 50¥22,866.60
MA 200¥17,272.00
MACDBearish
VolumeDecreasing
Fear & Greed Index85.46
Valuation
Target Price¥24,071.43
Upside/Downside-2.94%
GradeUndervalued
TypeBlend
Dividend Yield1.21%
Risk Assessment
Beta0.86
Volatility36.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.